| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |